NEXUS trial: A multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometast

Định dạng: PDF / Số trang: 7

Nhắn tin với admin nếu không tải được